Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.25 +0.05 (+2.32%)
As of: Oct 22, 2026 · 10:40 AM EDT

Rocket Pharmaceuticals (RCKT) Acquisitions (2018)

Updated

Rocket Pharmaceuticals (RCKT) recorded Acquisitions of $42.73 million in FY2022.

Analysis

Rocket Pharmaceuticals (RCKT) Acquisitions (2018) Analysis & Trends

  • Annual Acquisitions has a four-year compound annual growth rate of -13.5% (FY2018 to FY2022).
  • The FY2022 figure is the highest annual Acquisitions since FY2018.
  • Per Business Quant data, RCKT's Acquisitions was $76.35 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,166.12 Bn 1,134.70 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 634.67 Bn 553.20 Bn 17.26 Bn -17.24 Bn
3 AbbVie 503.03 Bn 476.14 Bn 12.70 Bn -
4 Merck 377.66 Bn 332.04 Bn 12.21 Bn -
5 Novartis Ag 303.82 Bn 267.81 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 266.80 Bn 240.49 Bn 12.86 Bn -
7 Amgen 240.87 Bn 196.27 Bn 7.24 Bn -
8 Gilead Sciences 193.45 Bn 167.65 Bn 6.22 Bn 11.21 Bn
9 Pfizer 172.20 Bn 118.84 Bn 10.94 Bn -
10 Rocket Pharmaceuticals 254.01 Mn -29.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 -76.35 Mn
API Access

Rocket Pharmaceuticals Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=RCKT&period=max&api_key=YOUR_API_KEY